Unknown

Dataset Information

0

IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.


ABSTRACT: Solid tumors are complex masses with a local microenvironment, or stroma, that supports tumor growth and progression. Among the diverse tumor-supporting stromal cells is a heterogeneous population of myeloid-derived cells. These cells are alternatively activated and contribute to the immunosuppressive environment of the tumor; overcoming their immunosuppressive effects may improve the efficacy of cancer immunotherapies. We recently found that engineering tumor-specific CD8(+) T cells to secrete the inflammatory cytokine IL-12 improved their therapeutic efficacy in the B16 mouse model of established melanoma. Here, we report the mechanism underlying this finding. Surprisingly, direct binding of IL-12 to receptors on lymphocytes or NK cells was not required. Instead, IL-12 sensitized bone marrow-derived tumor stromal cells, including CD11b(+)F4/80(hi) macrophages, CD11b(+)MHCII(hi)CD11c(hi) dendritic cells, and CD11b(+)Gr-1(hi) myeloid-derived suppressor cells, causing them to enhance the effects of adoptively transferred CD8(+) T cells. This reprogramming of myeloid-derived cells occurred partly through IFN-?. Surprisingly, direct presentation of antigen to the transferred CD8(+) T cells by tumor was not necessary; however, MHCI expression on host cells was essential for IL-12-mediated antitumor enhancements. These results are consistent with a model in which IL-12 enhances the ability of CD8(+) T cells to collapse large vascularized tumors by triggering programmatic changes in otherwise suppressive antigen-presenting cells within tumors and support the use of IL-12 as part of immunotherapy for the treatment of solid tumors.

SUBMITTER: Kerkar SP 

PROVIDER: S-EPMC3226001 | biostudies-literature | 2011 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications


Solid tumors are complex masses with a local microenvironment, or stroma, that supports tumor growth and progression. Among the diverse tumor-supporting stromal cells is a heterogeneous population of myeloid-derived cells. These cells are alternatively activated and contribute to the immunosuppressive environment of the tumor; overcoming their immunosuppressive effects may improve the efficacy of cancer immunotherapies. We recently found that engineering tumor-specific CD8(+) T cells to secrete  ...[more]

Similar Datasets

| S-EPMC6315808 | biostudies-literature
| S-EPMC3341524 | biostudies-literature
| S-EPMC8571137 | biostudies-literature
| S-EPMC7318263 | biostudies-literature
| S-EPMC11292205 | biostudies-literature
| S-EPMC4404840 | biostudies-literature
| S-EPMC9009736 | biostudies-literature
| S-EPMC10565626 | biostudies-literature
| S-SCDT-10_15252-EMMM_202317691 | biostudies-other
| S-EPMC4886360 | biostudies-literature